[,ægcg1gygmg g ! ,æ0è9 õ fþ 2a 0É - qst · 2016-05-23 · p p=pnpnp=pap pr b op oúp p z8 }o...
TRANSCRIPT
![Page 1: [,æGcG1GyGMG G ! ,æ0è9 õ Fþ 2A 0É - QST · 2016-05-23 · p p=pnpNp=pAp pR B op oúp p Z8 }o Há=ì o } Ù [f W o pNp plpR B o p GØ= p ÝO Jp O JZ8 - x åo ô }o pNp plpR B](https://reader030.vdocument.in/reader030/viewer/2022011812/5e2d0154dc300a0f7b609cb3/html5/thumbnails/1.jpg)
![Page 2: [,æGcG1GyGMG G ! ,æ0è9 õ Fþ 2A 0É - QST · 2016-05-23 · p p=pnpNp=pAp pR B op oúp p Z8 }o Há=ì o } Ù [f W o pNp plpR B o p GØ= p ÝO Jp O JZ8 - x åo ô }o pNp plpR B](https://reader030.vdocument.in/reader030/viewer/2022011812/5e2d0154dc300a0f7b609cb3/html5/thumbnails/2.jpg)
•••••
![Page 3: [,æGcG1GyGMG G ! ,æ0è9 õ Fþ 2A 0É - QST · 2016-05-23 · p p=pnpNp=pAp pR B op oúp p Z8 }o Há=ì o } Ù [f W o pNp plpR B o p GØ= p ÝO Jp O JZ8 - x åo ô }o pNp plpR B](https://reader030.vdocument.in/reader030/viewer/2022011812/5e2d0154dc300a0f7b609cb3/html5/thumbnails/3.jpg)
5
Merck Japan company presentation March 20165
![Page 4: [,æGcG1GyGMG G ! ,æ0è9 õ Fþ 2A 0É - QST · 2016-05-23 · p p=pnpNp=pAp pR B op oúp p Z8 }o Há=ì o } Ù [f W o pNp plpR B o p GØ= p ÝO Jp O JZ8 - x åo ô }o pNp plpR B](https://reader030.vdocument.in/reader030/viewer/2022011812/5e2d0154dc300a0f7b609cb3/html5/thumbnails/4.jpg)
Merck Lifescience
Facts & Figures153,750
17,500
••
••
• PVDF•
![Page 5: [,æGcG1GyGMG G ! ,æ0è9 õ Fþ 2A 0É - QST · 2016-05-23 · p p=pnpNp=pAp pR B op oúp p Z8 }o Há=ì o } Ù [f W o pNp plpR B o p GØ= p ÝO Jp O JZ8 - x åo ô }o pNp plpR B](https://reader030.vdocument.in/reader030/viewer/2022011812/5e2d0154dc300a0f7b609cb3/html5/thumbnails/5.jpg)
3. April 2008, heipha GmbH, UE
Location:Lilienthalstraße 1669214 Eppelheim
Characteristics:: 4200 sqm
: 5800 sqm: 1000 sqm
: 48,5 x 108 m
Merck Lifescience
10
![Page 6: [,æGcG1GyGMG G ! ,æ0è9 õ Fþ 2A 0É - QST · 2016-05-23 · p p=pnpNp=pAp pR B op oúp p Z8 }o Há=ì o } Ù [f W o pNp plpR B o p GØ= p ÝO Jp O JZ8 - x åo ô }o pNp plpR B](https://reader030.vdocument.in/reader030/viewer/2022011812/5e2d0154dc300a0f7b609cb3/html5/thumbnails/6.jpg)
![Page 7: [,æGcG1GyGMG G ! ,æ0è9 õ Fþ 2A 0É - QST · 2016-05-23 · p p=pnpNp=pAp pR B op oúp p Z8 }o Há=ì o } Ù [f W o pNp plpR B o p GØ= p ÝO Jp O JZ8 - x åo ô }o pNp plpR B](https://reader030.vdocument.in/reader030/viewer/2022011812/5e2d0154dc300a0f7b609cb3/html5/thumbnails/7.jpg)
•
•••
![Page 8: [,æGcG1GyGMG G ! ,æ0è9 õ Fþ 2A 0É - QST · 2016-05-23 · p p=pnpNp=pAp pR B op oúp p Z8 }o Há=ì o } Ù [f W o pNp plpR B o p GØ= p ÝO Jp O JZ8 - x åo ô }o pNp plpR B](https://reader030.vdocument.in/reader030/viewer/2022011812/5e2d0154dc300a0f7b609cb3/html5/thumbnails/8.jpg)
••
•••
1.2.3.4.5.6.7.8.9.10.
![Page 9: [,æGcG1GyGMG G ! ,æ0è9 õ Fþ 2A 0É - QST · 2016-05-23 · p p=pnpNp=pAp pR B op oúp p Z8 }o Há=ì o } Ù [f W o pNp plpR B o p GØ= p ÝO Jp O JZ8 - x åo ô }o pNp plpR B](https://reader030.vdocument.in/reader030/viewer/2022011812/5e2d0154dc300a0f7b609cb3/html5/thumbnails/9.jpg)
• ISO 9001• ISO13485 EU
Key Focus AreasRegulatory Compliance US FDA 21
CFR Part 820EU Directives
98/79/EC, 93/42/EEC
JPAL –Pharmaceutical
Affairs Law
ISO:9001 (DQS), ISO:13485
(LNE/GMED)
Health Canada CMDR
(LNE/GMED)
18
ISO CertificationMerck Matrix Certification for all Merck sitesISO 13485 Certification for Cork
Merck Japan company presentation March 2016
![Page 10: [,æGcG1GyGMG G ! ,æ0è9 õ Fþ 2A 0É - QST · 2016-05-23 · p p=pnpNp=pAp pR B op oúp p Z8 }o Há=ì o } Ù [f W o pNp plpR B o p GØ= p ÝO Jp O JZ8 - x åo ô }o pNp plpR B](https://reader030.vdocument.in/reader030/viewer/2022011812/5e2d0154dc300a0f7b609cb3/html5/thumbnails/10.jpg)
•
•
• PET
•
•
![Page 11: [,æGcG1GyGMG G ! ,æ0è9 õ Fþ 2A 0É - QST · 2016-05-23 · p p=pnpNp=pAp pR B op oúp p Z8 }o Há=ì o } Ù [f W o pNp plpR B o p GØ= p ÝO Jp O JZ8 - x åo ô }o pNp plpR B](https://reader030.vdocument.in/reader030/viewer/2022011812/5e2d0154dc300a0f7b609cb3/html5/thumbnails/11.jpg)
33mm
QC
•• Vision System
•
•
•
![Page 12: [,æGcG1GyGMG G ! ,æ0è9 õ Fþ 2A 0É - QST · 2016-05-23 · p p=pnpNp=pAp pR B op oúp p Z8 }o Há=ì o } Ù [f W o pNp plpR B o p GØ= p ÝO Jp O JZ8 - x åo ô }o pNp plpR B](https://reader030.vdocument.in/reader030/viewer/2022011812/5e2d0154dc300a0f7b609cb3/html5/thumbnails/12.jpg)
•– 100→
–
•––
![Page 13: [,æGcG1GyGMG G ! ,æ0è9 õ Fþ 2A 0É - QST · 2016-05-23 · p p=pnpNp=pAp pR B op oúp p Z8 }o Há=ì o } Ù [f W o pNp plpR B o p GØ= p ÝO Jp O JZ8 - x åo ô }o pNp plpR B](https://reader030.vdocument.in/reader030/viewer/2022011812/5e2d0154dc300a0f7b609cb3/html5/thumbnails/13.jpg)
•
( )
→
![Page 14: [,æGcG1GyGMG G ! ,æ0è9 õ Fþ 2A 0É - QST · 2016-05-23 · p p=pnpNp=pAp pR B op oúp p Z8 }o Há=ì o } Ù [f W o pNp plpR B o p GØ= p ÝO Jp O JZ8 - x åo ô }o pNp plpR B](https://reader030.vdocument.in/reader030/viewer/2022011812/5e2d0154dc300a0f7b609cb3/html5/thumbnails/14.jpg)
••••
![Page 15: [,æGcG1GyGMG G ! ,æ0è9 õ Fþ 2A 0É - QST · 2016-05-23 · p p=pnpNp=pAp pR B op oúp p Z8 }o Há=ì o } Ù [f W o pNp plpR B o p GØ= p ÝO Jp O JZ8 - x åo ô }o pNp plpR B](https://reader030.vdocument.in/reader030/viewer/2022011812/5e2d0154dc300a0f7b609cb3/html5/thumbnails/15.jpg)
Lot
•Lot
•
•
![Page 16: [,æGcG1GyGMG G ! ,æ0è9 õ Fþ 2A 0É - QST · 2016-05-23 · p p=pnpNp=pAp pR B op oúp p Z8 }o Há=ì o } Ù [f W o pNp plpR B o p GØ= p ÝO Jp O JZ8 - x åo ô }o pNp plpR B](https://reader030.vdocument.in/reader030/viewer/2022011812/5e2d0154dc300a0f7b609cb3/html5/thumbnails/16.jpg)
31
![Page 17: [,æGcG1GyGMG G ! ,æ0è9 õ Fþ 2A 0É - QST · 2016-05-23 · p p=pnpNp=pAp pR B op oúp p Z8 }o Há=ì o } Ù [f W o pNp plpR B o p GØ= p ÝO Jp O JZ8 - x åo ô }o pNp plpR B](https://reader030.vdocument.in/reader030/viewer/2022011812/5e2d0154dc300a0f7b609cb3/html5/thumbnails/17.jpg)
•
•
![Page 18: [,æGcG1GyGMG G ! ,æ0è9 õ Fþ 2A 0É - QST · 2016-05-23 · p p=pnpNp=pAp pR B op oúp p Z8 }o Há=ì o } Ù [f W o pNp plpR B o p GØ= p ÝO Jp O JZ8 - x åo ô }o pNp plpR B](https://reader030.vdocument.in/reader030/viewer/2022011812/5e2d0154dc300a0f7b609cb3/html5/thumbnails/18.jpg)
•Web